We recently hosted a webinar on SDTM Trial Summary (TS) where Kristin Kelly discussed the minimum set of parameters to include in this essential domain and how to avoid triggering FDA rejection criteria.
If you missed it, check out the full webinar and slide deck on our blog. If you still have other questions, please feel free to contact us!